留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Streptozotocin induction of type 2 diabetes in tree shrew

Xiao-Yun WU Yun-Hai LI Qing CHANG Lin-Qiang ZHANG Sha-Sha LIAO Bin LIANG

Xiao-Yun WU, Yun-Hai LI, Qing CHANG, Lin-Qiang ZHANG, Sha-Sha LIAO, Bin LIANG. Streptozotocin induction of type 2 diabetes in tree shrew. Zoological Research, 2013, 34(2): 108-115. doi: 10.3724/SP.J.1141.2013.02108
Citation: Xiao-Yun WU, Yun-Hai LI, Qing CHANG, Lin-Qiang ZHANG, Sha-Sha LIAO, Bin LIANG. Streptozotocin induction of type 2 diabetes in tree shrew. Zoological Research, 2013, 34(2): 108-115. doi: 10.3724/SP.J.1141.2013.02108

链脲佐菌素诱导树鼩2型糖尿病

doi: 10.3724/SP.J.1141.2013.02108
基金项目: 生命科学领域基础前沿研究专项(KSCX2-EW-J-23); 中国科学院知识创新工程重要方向(KSCX2-EW-R-12); “863”计划(2012AA021801, 2012AA022402);西部之光“西部博士”项目(吴晓云);国家自然科学基金(U1202223, Y301261041)
详细信息
  • 中图分类号: Q493.4

Streptozotocin induction of type 2 diabetes in tree shrew

  • 摘要: 链脲佐菌素 (streptozotocin, STZ)是链球菌产生的天然化合物, 对哺乳动物的胰岛B 细胞有特异毒性, 被广泛用于诱导1 型和2 型糖尿病。该研究通过多次小剂量注射STZ 来建立树鼩2 型糖尿病动物模型。24 只树鼩被分为对照组以及60、70和80 mg/kg 剂量STZ 诱导组。注射STZ 后, 成模树鼩出现明显的多饮、多食和多尿症状, 平均体重未减轻, 高血糖症状持续8~16 周, 尿糖显著阳性, 肾功能及糖耐受明显受损, 糖脂代谢紊乱, 但未出现糖尿病乳酸中毒和高血糖高渗等并发症。该结果表明, 多次小剂量STZ 注射可诱导树鼩出现类似2 型糖尿病症状和糖尿病肾脏损伤, 且综合考虑STZ 注射次数、成模率以及成模稳定性, 两次注射80 mg/kg 剂量的STZ 较适合用于创建树鼩2 型糖尿病模型。
  • [1] Chinese Diabetes Society. 2011. Chinese Guideline for Type 2 Diabetes. Beijing: Peking University Medical Press. [中华医学会糖尿病学分会. 2011. 中国2型糖尿病防治指南. 北京: 北京大学医学出版社.]
    [2] Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC. 2011. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Laboratory Animals, 45(3): 131-140.
    [3] Erdal N, Gurgul S, Kavak S, Yildiz A, Emre M. 2011. Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats. Biological Trace Element Research, 140(3): 342-353.
    [4] Fuchs E. 1999. Tree shrews. In: Poole T, editor. UFAW handbook on the care and management of laboratory animals, vol. 1,7th ed. Terrestrial vertebrates. Oxford: Blackwell. 235–245.
    [5] Goldberg IJ. 2001. Clinical review 124: Diabetic dyslipidemia: causes and consequences. Journal of Clinical Endocrinology and Metabolism, 86(3): 965-971.
    [6] Ishiko S, Yoshida A, Mori F, Abiko T, Kitaya N, Kojima M, Saito K. 1997. Early ocular changes in a tree shrew model of diabetes. Nippon Ganka Gakkai Zasshi, 101(1): 19-23.
    [7] Junod A, Lambert AE, Stauffacher W, Renold AE. 1969. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. Journal of Clinical Investigation, 48(11): 2129-2139.
    [8] Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. 1967. Studies of the diabetogenic action of streptozotocin. Proceedings of the Society for Experimental Biology and Medicine, 126(1): 201-205.
    [9] Kavanagh K, Flynn DM, Nelson C, Zhang L, Wagner JD. 2011. Characterization and validation of a streptozotocin-induced diabetes model in the vervet monkey. Journal of Pharmacological and Toxicological Methods, 63(3): 296-303.
    [10] Kolb H, Kröncke KD. 1993. IDDM: lessons from the low-dose streptozotocin model in mice. Diabetes Reviews, 1: 116-126.
    [11] Koulmanda M, Qipo A, Chebrolu S, O'Neil J, Auchincloss H, Smith RN. 2003. The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis). American Journal of Transplantation, 3(3): 267-272.
    [12] Kramer J, Moeller EL, Hachey A, Mansfield KG, Wachtman LM. 2009. Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 296(3): R786-R793.
    [13] Kuttler B, Schneider E. 1982. Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence. Acta Biologica et Medica Germanica, 41(12): 1199-1202.
    [14] Li HY. 2010. A Study on Artificial Induced Type 2 Diabetes Mellitus Animal Models in Tree Shrews. Mastre's Degree thesis, Chinese Academy of Medical Sciences, Peking Union Medical College. [李海燕. 2010. 人工诱导树鼩2型糖尿病动物模型的研究. 硕士学位论文, 中国医学科学院, 北京协和医学院.]
    [15] Nain P, Saini V, Sharma S, Nain J. 2012. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. Journal of Ethnopharmacology, 142(1): 65-71.
    [16] Palm F, Ortsäter H, Hansell P, Liss P, Carlsson PO. 2004. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metabolism Research and Reviews, 20(6): 452-459.
    [17] Rabb GB, Getty RE, Williamson WM, Lombard LS. 1966. Spontaneous diabetes mellitus in tree shrews, Urogale everetti. Diabetes, 15(5): 327-330.
    [18] Rasch R. 1979. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia, 16(2): 125-128.
    [19] Rasch R. 1980. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Albumin excretion. Diabetologia, 18(5): 413-416.
    [20] Rerup CC. 1970. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacological Reviews, 22(4): 485-518.
    [21] Shaw JE, Sicree RA, Zimmet PZ. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87(1): 4-14.
    [22] Shepherd J. 1994. Diabetic dyslipidemia andatherosclerosis. Schweizerische Medizinische Wochenschrift, 124(44): 1933-1937.
    [23] Srinivasan,K., Ramarao, P. 2007. Animal models in type 2 diabetes research: An overview.Indian Journal of Medical Research. 125: 451-472.
    [24] Taskinen MR, Nikkila EA. 1979. Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia, 17(6): 351-356.
    [25] Ventura-Sobrevilla J, Boone-Villa VD, Aguilar CN, Román-Ramos R, Vega-Avila E, Campos-Sepulveda E, Alarcon-Aguilar F. 2011. Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. Proceedings of the Western Pharmacology Society, 54: 5-9.
    [26] Wagner, J.D., Kavanagh, K., Ward, G.M., Auerbach, B.J. et al. 2006. Old world nonhuman primates models of type 2 diabetes mellitus. ILAR Journal, 47(3): 259-71.
    [27] Wei LL, Lu YR, He SR, Jin X, Zeng L, Zhang S, Chen YN, Tian B, Mai G, Yang G, Zhang J, Wang L, Li HX, Markmann JF, Cheng JQ, Deng SP. 2011. Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin. Biochemical and Biophysical Research Communications, 412(2): 373-378.
    [28] Weiss RB. 1982. Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treatment Report, 66(3): 427-438.
    [29] Wu D, Zou C, Yue F, Li X, Li S, Zhang YA. 2009. The effect of long-term streptozotocin-induced diabetes mellitus (STZ-DM) on cynomolgus (Macaca fascicularis) monkeys. Journal of Medical Primatology, 38(1): 15-22.
    [30] Xian S, Huang S, Su JJ, Qin YF, Ou C, Luo ZJ, Wei MY. 2000. A study on experimental diabetes animal models in tree shrews induced by streptozotocin. Journal of Guangxi Medical University, 17(6): 945-949. [冼苏, 黄松, 苏建家, 秦映芬, 欧超, 罗佐杰, 韦敏怡. 2000. 链脲佐菌素诱导树鼩糖尿病动物模型研究. 广西医科大学学报, 17(6): 945-949.]
    [31] Yang SH, Dou KF, Song WJ. 2010. Prevalence of diabetes among men and women in China. New England Journal of Medicine, 362(25): 2425-2426.
    [32] Zafar M, Naqvi N, Ahmed M, Kaimkhani ZA. 2009. Altered kidney morphology and enzymes in streptozotocin induced diabetic rats. International Journal of Morphology, 27(3): 783-790.
  • 加载中
计量
  • 文章访问数:  1822
  • HTML全文浏览量:  64
  • PDF下载量:  2785
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-12-10
  • 修回日期:  2013-01-14
  • 刊出日期:  2013-04-08

目录

    /

    返回文章
    返回